SAMD9L and tuberculosis: Here we describe a pilot study to assay select, previously-validated, TB-associated immune mRNA biomarkers CALCOCO2, CD274, CD52, GBP1, IFIT3, IFITM3, SAMD9L, SNX10 and TMEM49 from our previous study (13), as protein targets.